Indaptus Therapeutics (INDP) Institutional Ownership $0.46 -0.01 (-2.13%) Closing price 05/2/2025 03:57 PM EasternExtended Trading$0.48 +0.02 (+3.70%) As of 05/2/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Indaptus Therapeutics (NASDAQ:INDP)CurrentInstitutional OwnershipPercentage7.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$31.88KNumber ofInstitutional Sellers(last 12 months)0 Get INDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INDP Institutional Buying and Selling by Quarter Indaptus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024Virtu Financial LLC14,232$32K0.0%N/A0.167% 11/9/2023Investment House LLC102,849$283K0.0%-5.0%1.224% 8/25/2023Strategy Asset Managers LLC45,336$87K0.0%-18.1%0.540% 8/8/2023Investment House LLC108,282$207K0.0%+13.2%1.289% 10/11/2022Strategy Asset Managers LLC55,336$120K0.0%N/A0.670% 7/22/2022 Stratos Wealth Partners LTD.26,832$70K0.0%-97.7%0.325% 4/26/2022 Stratos Wealth Partners LTD.1,188,356$4.75M0.1%-14.4%14.389% 2/9/2022Investment House LLC95,629$545K0.0%+272.8%1.167% 1/14/2022 Stratos Wealth Partners LTD.1,388,356$7.91M0.2%N/A16.952% 11/15/2021Marshall Wace LLP12,780$100K0.0%N/A0.236% 10/25/2021 Harel Insurance Investments & Financial Services Ltd.2,958$25K0.0%N/A0.055% (Data available from 1/1/2016 forward) INDP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INDP shares? During the previous two years, the following institutional investors and hedge funds held shares of Indaptus Therapeutics shares: Investment House LLC ($283K), and Strategy Asset Managers LLC ($87K), Virtu Financial LLC ($32K).Learn more on INDP's institutional investors. What percentage of Indaptus Therapeutics stock is owned by institutional investors? 7.06% of Indaptus Therapeutics stock is owned by institutional investors. Learn more on INDP's institutional investor holdings. Which institutional investors have been buying Indaptus Therapeutics stock? The following institutional investors have purchased Indaptus Therapeutics stock in the last 24 months: Virtu Financial LLC ($14.23K), and Investment House LLC ($12.65K). How much institutional buying is happening at Indaptus Therapeutics? Institutional investors have bought a total of 26,885 shares in the last 24 months. This purchase volume represents approximately $56.05K in transactions. Which Indaptus Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Indaptus Therapeutics stock in the last 24 months: Strategy Asset Managers LLC ($10K), and Investment House LLC ($5.43K). How much institutional selling is happening at Indaptus Therapeutics? Institutional investors have sold a total of 15,433 shares in the last 24 months. This volume of shares sold represents approximately $34.07K in transactions. Related Companies MRNS Major Shareholders KZR Major Shareholders INKT Major Shareholders ALLK Major Shareholders GBIO Major Shareholders ALXO Major Shareholders TPST Major Shareholders CLNN Major Shareholders BCAB Major Shareholders CGTX Major Shareholders This page (NASDAQ:INDP) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INDP Stock Free INDP Stock Alerts